2023
|
Invention
|
Therapeutic and diagnostic methods for multiple sclerosis. The present invention is directed to m... |
2021
|
Invention
|
Process for preparing alpha-carboxamide pyrrolidine derivatives.
The disclosure relates to novel... |
|
Invention
|
Process for preparing spiro derivatives.
The invention relates to a novel process for preparing ... |
|
Invention
|
Diagnostic method.
The invention relates to a method of diagnosing a paroxysmal pain disorder, s... |
2020
|
Invention
|
Method for treating joint damage.
Methods of treating joint damage in a subject eligible for tre... |
|
Invention
|
Processes for preparing alpha-carboxamide pyrrolidine derivatives.
The disclosure provides proce... |
|
Invention
|
Processes for preparing alpha-carboxamide pyrrolidine derivatives. The disclosure provides proces... |
|
Invention
|
Processes for preparing alpha-carboxamide pyrrolidine derivatives. SRR)-5-(4-((2-fluorobenzyl)oxy... |
2019
|
Invention
|
Method for treating joint damage. Methods of treating joint damage in a subject eligible for trea... |
2018
|
Invention
|
Process for preparing spiro derivatives. The invention relates to a novel process for preparing S... |
|
Invention
|
Process for preparing spiro derivatives. The invention relates to a novel process for preparing s... |
|
Invention
|
Process for preparing alpha-carboxamide pyrrolidine derivatives. The invention relates to a novel... |
|
Invention
|
Process for preparing alpha-carboxamide pyrolidine derivatives. The invention relates to a novel ... |
|
Invention
|
Novel salts.
The invention relates to novel salts of 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)... |
|
Invention
|
Novel salts. The invention relates to novel salts of 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)-... |
|
Invention
|
Novel crystalline forms. The present invention is directed to novel crystalline forms of 5-(4-{[(... |
|
Invention
|
Treatment of autoimmune diseases.
The present invention concerns treatment of autoimmune disease... |
2017
|
Invention
|
Treatment of diffuse large-cell lymphoma with anti-cd20 antibody. The present invention concerns ... |
|
Invention
|
Novel dosage regimen. The present invention is directed to a novel method of treating a disease o... |
2016
|
Invention
|
Treatment of diffuse large-cell lymphoma with anti-cd20 antibody.
The present invention concerns... |
|
Invention
|
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody.
New ... |
|
Invention
|
Methods of treating inflammatory and autoimmune diseases with natalizumab.
Natalizumab is a safe... |
|
Invention
|
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody. New c... |
2015
|
Invention
|
Compositions and methods for treatment of sickle cell disease.
This invention relates to methods... |
|
Invention
|
Compositions and methods for treatment of sickle cell disease. This invention relates to methods ... |
2014
|
Invention
|
Methods for increasing polypeptide recovery. The present invention pertains to a method for purif... |
|
Invention
|
Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt... |
2012
|
Invention
|
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies. New... |
2011
|
Invention
|
Enrichment and concentration of select product isoforms by overloaded bind and elute chromatograp... |
2010
|
Invention
|
Treatment of vasculitis. The present invention concerns treatment of autoimmune diseases with ant... |
|
Invention
|
Use of bcma as an immunoregulatory agent.
The disclosure relates to B-cell maturation antigen (B... |
|
Invention
|
Methods of treating inflammatory and autoimmune diseases with natalizumab. Natalizumab is a safe ... |
2009
|
Invention
|
Treatment of chronic lymphocytic leukemia using anti-cd20 antibodies. Chronic Lymphocytic Leukemi... |
2007
|
Invention
|
Methods of treating rheumatoid arthritis with 7c10 and 16c10 cd80-specific antibodies. The presen... |
2000
|
Invention
|
Treatment of aggressive non-hodgkins lymphoma with anti-cd20 antibody. This invention concerns me... |
|
Invention
|
Treatment of autoimmune diseases. Methods are disclosed of treating rheumatoid arthritis in a hum... |
1999
|
Invention
|
Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti... |